August 16, 2025 - 17:26

Tuniu has reported impressive results for the second quarter of 2025, showcasing a robust 15.3% increase in revenue compared to the previous year. This growth marks a significant milestone for the company, reflecting its commitment to innovation and the development of targeted solutions within the travel technology sector.
The return to profitability is a noteworthy achievement, highlighting Tuniu's effective strategies in adapting to the evolving demands of the travel market. The company's focus on enhancing user experience through advanced technology and personalized services has resonated well with consumers, contributing to the overall revenue boost.
As the travel industry continues to rebound, Tuniu's proactive approach positions it favorably for future growth. The company’s dedication to leveraging technology to streamline travel planning and enhance customer satisfaction is expected to play a crucial role in its ongoing success. Tuniu's latest results underscore its potential to shape the future of travel technology in a competitive landscape.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...